Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi V Russell

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Surgery|January 9, 2007
Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastomaSanjeev A Vasudevan, Heidi V Russell, M Fatih Okcu, et al.
Cancer|October 8, 2021
Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology GroupHeidi V Russell, Yueh-Yun Chi, M Fatih Okcu, et al.
Cancer Research|January 2, 2009
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cellsTasnim Ara, Liping Song, Hiroyuki Shimada, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 28, 2020
Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditionsHadley Stevens Smith, John M Swint, Seema R Lalani, et al.
Proteomics. Clinical Applications|August 12, 2011
An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoringRachel A Egler, Yiting Li, Tu Anh T Dang, et al.
BMC Medical Informatics and Decision Making|October 3, 2014
Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admissionHeidi V Russell, M Fatih Okcu, Kala Kamdar, et al.
Molecular Cancer Therapeutics|August 13, 2009
Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastomaXiaoying Shang, Susan M Burlingame, M Fatih Okcu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 16, 2018
Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the LiteratureHadley Stevens Smith, J Michael Swint, Seema R Lalani, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2007
Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinasesMassimiliano De Bortoli, Robert C Castellino, Darlene G Skapura, et al.
Journal of Pediatric Surgery|June 20, 2016
The optimal timing of surgical resection in high-risk neuroblastomaYesenia Rojas, Sergio Jaramillo, Karen Lyons, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Surgery|January 9, 2007
Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastomaSanjeev A Vasudevan, Heidi V Russell, M Fatih Okcu, et al.
Cancer|October 8, 2021
Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology GroupHeidi V Russell, Yueh-Yun Chi, M Fatih Okcu, et al.
Cancer Research|January 2, 2009
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cellsTasnim Ara, Liping Song, Hiroyuki Shimada, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 28, 2020
Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditionsHadley Stevens Smith, John M Swint, Seema R Lalani, et al.
Proteomics. Clinical Applications|August 12, 2011
An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoringRachel A Egler, Yiting Li, Tu Anh T Dang, et al.
BMC Medical Informatics and Decision Making|October 3, 2014
Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admissionHeidi V Russell, M Fatih Okcu, Kala Kamdar, et al.
Molecular Cancer Therapeutics|August 13, 2009
Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastomaXiaoying Shang, Susan M Burlingame, M Fatih Okcu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 16, 2018
Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the LiteratureHadley Stevens Smith, J Michael Swint, Seema R Lalani, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2007
Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinasesMassimiliano De Bortoli, Robert C Castellino, Darlene G Skapura, et al.
Journal of Pediatric Surgery|June 20, 2016
The optimal timing of surgical resection in high-risk neuroblastomaYesenia Rojas, Sergio Jaramillo, Karen Lyons, et al.
Pageof 5